幽门螺杆菌感染后胃癌风险因素与发病率:大型队列研究
该回顾性队列研究纳入美国退伍军人健康管理局371,813例幽门螺杆菌感染者,分析感染后非近端胃腺癌的累积发病率及风险因素。结果显示5、10、20年累积发病率分别为0.37%、0.5%、0.65%,高龄、非白种族、西班牙裔及吸烟史与风险升高相关,成功根除治疗可显著降低风险。
要点
- 幽门螺杆菌感染后20年胃癌累积发病率0.65%,总体风险较低但存在高危人群。
- 非白种族、西班牙裔、吸烟史及高龄是胃癌独立危险因素。
- 仅确认根除治疗成功方可降低胃癌风险,单纯治疗未根除者风险仍高。
核心结论
- 幽门螺杆菌感染后胃癌风险在种族少数群体和吸烟者中显著升高。
- 治疗幽门螺杆菌仅在成功根除时才降低胃癌风险。
- 需要研究高危人群筛查及诊断、耐药和治疗疗效的质量措施。
研究设计与样本
- 回顾性队列研究,数据来自美国退伍军人健康管理局。
- 主要结局为幽门螺杆菌感染检测30天及以后诊断的远端胃腺癌。
- 采用竞争风险分析(以癌症前死亡为竞争风险)。
主要发现
- 感染检测后5、10、20年胃癌累积发病率分别为0.37%、0.5%、0.65%。
- 高龄(SHR 1.13;95%CI 1.11-1.15;P<.001)、黑种人/非裔美国人(SHR 2.00;95%CI 1.80-2.22)、亚洲人(SHR 2.52;95%CI 1.64-3.89)(种族P<.001)、西班牙裔或拉丁裔(SHR 1.59;95%CI 1.34-1.87;P<.001)及吸烟史(SHR 1.38;95%CI 1.25-1.52;P<.001)与癌症风险升高相关。
- 女性较男性胃癌风险降低(SHR 0.52;95%CI 0.40-0.68;P<.001)。
- 基于血清抗体阳性检测出幽门螺杆菌感染的患者癌症风险降低(SHR 0.74;95%CI 0.54-1.04;P=.04)。
- 接受幽门螺杆菌治疗的患者胃癌风险仍升高(SHR 1.16;95%CI 0.74-1.83;P=.51),但确认根除后风险降低(SHR 0.24;95%CI 0.15-0.41;P<.001)。
关键数值与推荐
- 幽门螺杆菌感染检测后5年胃癌累积发病率0.37%。
- 幽门螺杆菌感染检测后10年胃癌累积发病率0.5%。
- 幽门螺杆菌感染检测后20年胃癌累积发病率0.65%。
- 确认根除后胃癌风险SHR 0.24(95%CI 0.15-0.41;P<.001)。
临床怎么用
- 对幽门螺杆菌感染者应评估高龄、非白种族、西班牙裔及吸烟史等高危因素。
- 治疗幽门螺杆菌后应确认根除,以降低胃癌风险。
- 对高危人群可考虑进一步筛查,但需研究支持。
局限性
- 回顾性队列研究,可能存在未测量混杂。
- 研究人群以男性退伍军人为主(92.3%),外推性受限。
- 幽门螺杆菌诊断方法包括血清抗体,可能影响感染确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Nearly all studies of gastric adenocarcinoma in the United States have relied on national cancer databases, which do not include data on Helicobacter pylori infection, the most well-known risk factor for gastric cancer. We collected data from a large cohort of patients in the United States to calculate the incidence of and risk factors for nonproximal gastric adenocarcinomas after detection of H pylori. Secondary aims included identifying how treatment and eradication affect cancer risk. METHODS: We performed a retrospective cohort study, collecting data from the Veterans Health Administration on 371,813 patients (median age 62 years; 92.3% male) who received a diagnosis of H pylori infection from January 1, 1994, through December 31, 2018. The primary outcome was a diagnosis of distal gastric adenocarcinoma 30 days or more after detection of H pylori infection. We performed a time to event with competing risk analysis (with death before cancer as a competing risk). RESULTS: The cumulative incidence of cancer at 5, 10, and 20 years after detection of H pylori infection was 0.37%, 0.5%, and 0.65%, respectively. Factors associated with cancer included older age at time of detection of H pylori infection (subhazard ratio [SHR], 1.13; 95% confidence interval [CI], 1.11-1.15; P < .001), black/African American race (SHR, 2.00; 95% CI, 1.80-2.22), Asian race (SHR, 2.52; 95% CI, 1.64-3.89) (P < .001 for race), Hispanic or Latino ethnicity (SHR, 1.59; 95% CI, 1.34-1.87; P < .001), and history of smoking (SHR, 1.38; 95% CI, 1.25-1.52; P < .001). Women had decreased risk of gastric adenocarcinoma compared with men (SHR, 0.52; 95% CI, 0.40-0.68; P < .001); patients whose H pylori infection was detected based on serum antibody positivity also had a reduced risk of cancer (SHR 0.74; 95% CI, 0.54-1.04; P = .04). Patients who received treatment for their H pylori infection still had an increased risk of gastric cancer (SHR, 1.16; 95% CI, 0.74-1.83; P = .51) but confirmed H pylori eradication after treatment reduced risk of gastric cancer (SHR, 0.24; 95% CI, 0.15-0.41; P < .001). CONCLUSIONS: In a study of 371,813 veterans with a diagnosis of H pylori infection, we found significantly higher risks of gastric cancer in racial and ethnic minorities and smokers. Treatment of H pylori infection decreased risk only if eradication was successful. Studies are needed on the effects of screening high-risk persons and to identify quality measures for diagnosis, resistance patterns, and treatment efficacy.
引用
- Kumar S, Metz DC, Ellenberg S, et al. Risk Factors and Incidence of Gastric Cancer After Detection of Helicobacter pylori Infection: A Large Cohort Study. Gastroenterology. 2019. PMID: 31654635. doi:10.1053/j.gastro.2019.10.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。